PetMed Express, Inc. (NASDAQ:PETS) Sees Significant Decrease in Short Interest

Posted by Stanley Muller on Jul 29th, 2026

PetMed Express, Inc. (NASDAQ:PETS – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 914,046 shares, a decline of 43.5% from the June 30th total of 1,617,488 shares. Approximately 4.3% of the company’s shares are short sold. Based on an average daily trading volume, of 245,985 shares, the days-to-cover ratio is presently 3.7 days.

Hedge Funds Weigh In On PetMed Express

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Goldman Sachs Group Inc. grew its stake in shares of PetMed Express by 59.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 33,209 shares of the company’s stock valued at $139,000 after buying an additional 12,360 shares during the period. Occudo Quantitative Strategies LP bought a new position in PetMed Express in the second quarter worth approximately $51,000. Bridgeway Capital Management LLC grew its stake in PetMed Express by 96.2% in the second quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company’s stock valued at $135,000 after acquiring an additional 20,000 shares during the period. Oxford Asset Management LLP acquired a new stake in PetMed Express in the second quarter valued at approximately $55,000. Finally, Dimensional Fund Advisors LP increased its holdings in shares of PetMed Express by 5.4% during the third quarter. Dimensional Fund Advisors LP now owns 481,517 shares of the company’s stock valued at $1,209,000 after acquiring an additional 24,624 shares in the last quarter. Institutional investors own 73.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Wall Street Zen raised PetMed Express from a “strong sell” rating to a “hold” rating in a research note on Saturday, June 6th. Zacks Research raised PetMed Express to a “hold” rating in a research note on Thursday, April 30th. Finally, Weiss Ratings cut PetMed Express from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, PetMed Express presently has a consensus rating of “Reduce”.

Check Out Our Latest Stock Report on PetMed Express

PetMed Express Stock Down 1.7%

PETS traded down $0.04 during trading on Wednesday, hitting $1.98. The company’s stock had a trading volume of 21,956 shares, compared to its average volume of 365,992. The firm has a market capitalization of $42.21 million, a P/E ratio of -0.72 and a beta of 0.77. PetMed Express has a twelve month low of $1.57 and a twelve month high of $4.10. The stock’s fifty day moving average price is $1.94 and its 200-day moving average price is $2.41.

PetMed Express (NASDAQ:PETS – Get Free Report) last released its earnings results on Tuesday, June 2nd. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). The company had revenue of $42.82 million for the quarter, compared to analyst estimates of $52.00 million. PetMed Express had a negative net margin of 32.00% and a negative return on equity of 76.86%. During the same quarter in the previous year, the firm earned ($0.56) EPS. Equities research analysts expect that PetMed Express will post 0.07 EPS for the current fiscal year.

About PetMed Express

(Get Free Report)

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.